| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI115872 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC443112 |
| https://europepmc.org/articles/PMC443112?pdf=render | ||
| P932 | PMC publication ID | 443112 |
| P698 | PubMed publication ID | 1322938 |
| P5875 | ResearchGate publication ID | 21832647 |
| P50 | author | Laurent P Nicod | Q37368680 |
| P2093 | author name string | H. G. Welgus | |
| B. Galve-de Rochemonteix | |||
| C. Baumberger | |||
| J. M. Dayer | |||
| S. Lacraz | |||
| P2860 | cites work | B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells | Q68798792 |
| Interferon-gamma induction of LFA-1-mediated homotypic adhesion of human monocytes | Q68963617 | ||
| Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase | Q69353314 | ||
| Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media | Q69550650 | ||
| Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma | Q70051187 | ||
| All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma | Q70294311 | ||
| Polypeptides of the tail fibres of bacteriophage T4 | Q70644553 | ||
| Enzyme-linked immunosorbent assay for human skin collagenase | Q72705186 | ||
| Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages | Q28302840 | ||
| Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2 | Q33858688 | ||
| Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma | Q34261766 | ||
| Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development | Q34263093 | ||
| Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells | Q34350582 | ||
| Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells | Q34522610 | ||
| Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor | Q34542804 | ||
| Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. | Q35595667 | ||
| Identification of a T cell-derived b cell growth factor distinct from interleukin 2. | Q36346214 | ||
| Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts | Q36351406 | ||
| Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness | Q36354289 | ||
| Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization | Q37594710 | ||
| Superoxide dismutase activity in thermally stressed Staphylococcus aureus | Q40079472 | ||
| Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production | Q40344443 | ||
| 12-o-Tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases. High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. | Q40922861 | ||
| Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts | Q41015869 | ||
| Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). | Q41678253 | ||
| Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages | Q41720046 | ||
| Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages | Q42466536 | ||
| Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA) | Q46724375 | ||
| Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium | Q46909543 | ||
| Human 92- and 72-kilodalton type IV collagenases are elastases | Q67915576 | ||
| Immunobiochemical evidence for the loss of sperm specific histones during male pronucleus formation in monospermic zygotes of sea urchins | Q68041360 | ||
| Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4 | Q68128479 | ||
| Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases | Q68190931 | ||
| Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes | Q68357466 | ||
| IL-4 decreases Fc gamma R membrane expression and Fc gamma R-mediated cytotoxic activity of human monocytes | Q68415018 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 382-388 | |
| P577 | publication date | 1992-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4 | |
| P478 | volume | 90 |
| Q24648943 | 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection |
| Q35832706 | 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma |
| Q36648938 | A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells |
| Q47739552 | A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells |
| Q40788291 | Adhesion molecules and cytokine production |
| Q33883632 | Advances in immunopharmacology of asthma |
| Q42473308 | Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells |
| Q41481774 | Collagenase: a key enzyme in collagen turnover |
| Q72333296 | Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis |
| Q77627762 | Cytokine therapy in rheumatoid arthritis |
| Q36188431 | Cytokines and cardiovascular disease |
| Q33717312 | Cytokines in asthma |
| Q40832086 | Cytokines. 1. Overview |
| Q92091020 | Deriving a Boolean dynamics to reveal macrophage activation with in vitro temporal cytokine expression profiles |
| Q36173452 | Douchi (fermented Glycine max Merr.) alleviates atopic dermatitis-like skin lesions in NC/Nga mice by regulation of PKC and IL-4. |
| Q36752124 | Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity? |
| Q78074203 | Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone |
| Q42484544 | Evaluation of inflammatory cytokine secretion by human alveolar macrophages |
| Q43578009 | Human lung tissue macrophages, but not alveolar macrophages, express matrix metalloproteinases after direct contact with activated T lymphocytes |
| Q35766246 | IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes |
| Q44475267 | IL-10 signaling via IL-10E1 is dependent on tyrosine phosphorylation in the IL-10R alpha chain in human primary prostate cancer cell lines |
| Q36000360 | Imaging of macrophage-related lung diseases |
| Q24532069 | Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes |
| Q74194888 | Implication of interleukin-4 in wound healing |
| Q74088290 | Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) |
| Q35888047 | Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy |
| Q38013061 | Inflammatory markers in coronary artery disease. |
| Q44366487 | Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis |
| Q54756327 | Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. |
| Q36705701 | Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor [corrected] of matrix metalloproteinase-1 in myocardial infarction |
| Q54221109 | Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts. |
| Q73831581 | Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor |
| Q71942074 | Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines |
| Q35795586 | Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. |
| Q38583149 | Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. |
| Q35782114 | Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity |
| Q34730833 | Lower expression of inducible nitric oxide synthase and higher expression of arginase in rat alveolar macrophages are linked to their susceptibility to Toxoplasma gondii infection |
| Q73266466 | Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma |
| Q47683108 | Matrix Metalloproteinases in the Hematopoietic Microenvironment |
| Q35577632 | Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study |
| Q41191469 | Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells |
| Q36752100 | Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability |
| Q39100850 | Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging |
| Q35745195 | Morphine Modulates Interleukin-4- or Breast Cancer Cell-induced Pro-metastatic Activation of Macrophages |
| Q71548688 | Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells |
| Q77995177 | Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid |
| Q34276030 | Potential biologic agents for treating rheumatoid arthritis |
| Q35750610 | Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages |
| Q24803611 | Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies |
| Q33578432 | Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4 |
| Q35150958 | Prospects for the medical management of abdominal aortic aneurysms |
| Q24792053 | Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis |
| Q51651457 | Regulation of procollagen I (α1) by interleukin‐4 in human bronchial fibroblasts: a possible role in airway remodelling in asthma |
| Q40575091 | Regulation of proteolytic activity in tissues |
| Q34158420 | Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis |
| Q41062476 | Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas |
| Q84080422 | The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1) |
| Q35749882 | The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor |
| Q47222545 | The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease |
| Q54540997 | The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts. |
| Q82928639 | Visfatin levels and intima-media thicknesses in rheumatic diseases |
Search more.